| Date | Event |
| 7-Dec-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pri |
| 16-Nov-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report |
| 22-Sep-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K/A, Termination of a Material Definitive Agreement, Other Events |
| 22-Sep-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events |
| 18-Sep-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or |
| 8-Sep-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Change in Directors or Principal Officers |
| 17-Aug-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report |
| 30-Jul-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events |
| 23-Jul-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events |
| 12-Jun-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events |
| 18-May-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report |
| 24-Apr-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors |
| 9-Apr-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or |
| 31-Mar-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 10-K, Annual Report |
| 5-Mar-09 | Price hit new 52-week low ($0.04) |
| 26-Feb-09 | Price hit new 52-week low ($0.05) |
| 24-Feb-09 | Price hit new 52-week low ($0.07) |
| 23-Feb-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events |
| 12-Feb-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events |
| 2-Feb-09 | Price hit new 52-week high ($2.91) |
| 28-Jan-09 | Price hit new 52-week high ($2.43) |
| 26-Jan-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equit |
| 6-Jan-09 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 4-Dec-08 | LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to R |
| 10-Nov-08 | LA JOLLA PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report |